170 related articles for article (PubMed ID: 31514233)
1. The efficacy and safety of thalidomide on the recurrence interval of continuous recurrent aphthous ulceration: A randomized controlled clinical trial.
Zeng Q; Shi X; Yang J; Yang M; Zhao W; Zhao X; Shi J; Zhou H
J Oral Pathol Med; 2020 Apr; 49(4):357-364. PubMed ID: 31514233
[TBL] [Abstract][Full Text] [Related]
2. A Randomized controlled clinical trial on dose optimization of thalidomide in maintenance treatment for recurrent aphthous stomatitis.
Deng Y; Wei W; Wang Y; Pan L; Du G; Yao H; Tang G
J Oral Pathol Med; 2022 Jan; 51(1):106-112. PubMed ID: 34773292
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports.
Shetty K
Spec Care Dentist; 2005; 25(5):236-41. PubMed ID: 16454100
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N
J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
[TBL] [Abstract][Full Text] [Related]
6. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C
Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration.
Liu C; Zhou Z; Liu G; Wang Q; Chen J; Wang L; Zhou Y; Dong G; Xu X; Wang Y; Guo Y; Lin M; Wu L; Du G; Wei C; Zeng X; Wang X; Wu J; Li B; Zhou G; Zhou H
Am J Med; 2012 Mar; 125(3):292-301. PubMed ID: 22340928
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
[TBL] [Abstract][Full Text] [Related]
9. Dynamic salivary cytokine profile of recurrent aphthous stomatitis patients in thalidomide maintenance treatment.
Wei W; Deng Y; Wang Y; Yao H; Du G; Tang G
Clin Oral Investig; 2024 Feb; 28(2):140. PubMed ID: 38334890
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for recurrent oral aphthous ulcers.
Barrons RW
Am J Health Syst Pharm; 2001 Jan; 58(1):41-50; quiz 51-3. PubMed ID: 11194135
[TBL] [Abstract][Full Text] [Related]
11. Recurrent giant aphthous ulcers in a child: protracted treatment with thalidomide.
Menni S; Imondi D; Brancaleone W; Croci S
Pediatr Dermatol; 1993 Sep; 10(3):283-5. PubMed ID: 8415309
[TBL] [Abstract][Full Text] [Related]
12. Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis.
Hello M; Barbarot S; Bastuji-Garin S; Revuz J; Chosidow O
Medicine (Baltimore); 2010 May; 89(3):176-182. PubMed ID: 20453604
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide in severe orogenital ulceration.
Jenkins JS; Powell RJ; Allen BR; Littlewood SM; Maurice PD; Smith NJ
Lancet; 1984 Dec; 2(8417-8418):1424-6. PubMed ID: 6151044
[TBL] [Abstract][Full Text] [Related]
14. Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy.
Femiano F; Buonaiuto C; Gombos F; Lanza A; Cirillo N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):402-7. PubMed ID: 19926502
[TBL] [Abstract][Full Text] [Related]
15. Topical lavender oil for the treatment of recurrent aphthous ulceration.
Altaei DT
Am J Dent; 2012 Feb; 25(1):39-43. PubMed ID: 22558691
[TBL] [Abstract][Full Text] [Related]
16. Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU).
Skaare AB; Herlofson BB; Barkvoll P
J Clin Periodontol; 1996 Aug; 23(8):778-81. PubMed ID: 8877665
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
[TBL] [Abstract][Full Text] [Related]
18. A clinical evaluation of 5% amlexanox oral paste in the treatment of minor recurrent aphthous ulcers and comparison with the placebo paste: a randomized, vehicle controlled, parallel, single center clinical trial.
Bhat S; Sujatha D
Indian J Dent Res; 2013; 24(5):593-8. PubMed ID: 24355961
[TBL] [Abstract][Full Text] [Related]
19. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
Cheng S; Murphy R
Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
[TBL] [Abstract][Full Text] [Related]
20. A trial of cromoglycic acid in recurrent aphthous ulceration.
Dolby AE; Walker DM
Br J Oral Surg; 1975 Mar; 12(3):292-5. PubMed ID: 804914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
